Jiaqi Ji

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Prognostic value of baseline serum KL-6 for mortality risk in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy: A retrospective cohort study.

Prognostic value of baseline serum KL-6 for mortality risk in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy: A retrospective cohort study.

Journal: Therapeutic advances in respiratory disease

Published: August 31, 2026

Admission Serum KL-6 Predicts Mechanical Ventilation Requirement and Mortality in Hospitalized Interstitial Lung Disease Patients: A Single-Center Prospective Study.

Admission Serum KL-6 Predicts Mechanical Ventilation Requirement and Mortality in Hospitalized Interstitial Lung Disease Patients: A Single-Center Prospective Study.

Journal: Lung

Published: February 09, 2026

Associated factors in the development of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis.

Associated factors in the development of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis.

Journal: Frontiers in immunology

Published: May 15, 2025

Risk factors for mortality in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a systematic review and meta-analysis.

Risk factors for mortality in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a systematic review and meta-analysis.

Journal: Frontiers in immunology

Published: May 14, 2025

Efficacy of pulmonary rehabilitation on health-related quality of life in patients with interstitial lung disease as assessed by SF-36: a systematic review and meta-analysis.

Efficacy of pulmonary rehabilitation on health-related quality of life in patients with interstitial lung disease as assessed by SF-36: a systematic review and meta-analysis.

Journal: European journal of physical and rehabilitation medicine

Published: April 03, 2025

A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease.

A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease.

Journal: Frontiers in medicine

Published: January 10, 2025

Prognostic factors in hospitalized patients with COVID-19 pneumonia and effectiveness of prophylactic anticoagulant therapy: a single-center retrospective study.

Prognostic factors in hospitalized patients with COVID-19 pneumonia and effectiveness of prophylactic anticoagulant therapy: a single-center retrospective study.

Journal: BMC infectious diseases

Published: November 05, 2024

Risk factors for poor prognosis in ANCA-associated vasculitis with interstitial lung disease: a systematic review and meta-analysis.

Risk factors for poor prognosis in ANCA-associated vasculitis with interstitial lung disease: a systematic review and meta-analysis.

Journal: Clinical rheumatology

Published: October 22, 2024

Surfactant protein A as an important biomarker for interstitial lung disease in the assessment of occurrence, progression, acute exacerbation, and mortality: A systematic review and meta-analysis.

Surfactant protein A as an important biomarker for interstitial lung disease in the assessment of occurrence, progression, acute exacerbation, and mortality: A systematic review and meta-analysis.

Journal: Medicine

Published: August 23, 2024

Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis.

Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis.

Journal: Frontiers in immunology

Published: June 18, 2024

Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study.

Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study.

Journal: Annals of medicine

Published: April 06, 2024

Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Journal: Annals of medicine

Published: February 01, 2024

Showing 1-12 of 15

Last Updated: 09/26/2026